Andrology and Fertility Hospital of Hanoi (Drs. Trinh, H.V. Pham, Ho, Le, and H.M. Pham and Ms. H. Nguyen), Hanoi, Vietnam.
Robinson Research Institute, The University of Adelaide, School of Medicine (Drs. K. Nguyen and O'Leary), Adelaide, Australia.
J Minim Invasive Gynecol. 2022 Feb;29(2):284-290. doi: 10.1016/j.jmig.2021.08.010. Epub 2021 Aug 22.
To compare the recurrence rate, post-treatment American Fertility Society (AFS) score, ongoing pregnancy rate, and endometrial thickness of 3 secondary prevention therapies in preventing recurrent intrauterine adhesions (IUAs) and increasing pregnancy rates in infertile women after hysteroscopic adhesiolysis.
A retrospective study.
A private fertility hospital.
A total of 200 consecutive infertile women, with the desire to have a baby and were diagnosed as having IUAs detected by hysterosalpingogram, who underwent hysteroscopic adhesiolysis for IUAs from January, 2018 to May, 2020.
Women who underwent hysteroscopic adhesiolysis received hormone therapy, and one of the 3 secondary preventions: hyaluronic acid (HA) gel alone, intrauterine devices (IUDs) alone, or HA gel + IUD.
Of the 200 women included in the final analysis, 121 received HA alone, 59 were treated with IUD alone, and 20 received HA gel + IUD combination. The mean post-treatment AFS score for IUAs was significantly lower in the HA gel + IUD group than the HA alone or the IUD alone groups (adjusted p = .01 and p = .02, respectively). Multivariable analysis revealed a significantly lower recurrence rate in the women after treatment with HA gel + IUD than HA alone (adjusted odds ratio, 0.19; 95% credible interval [CreI], 0.03-0.88). Women treated with HA gel + IUD also had reduced post-treatment AFS scores compared with HA alone (β coefficients, -0.83; 95% CreI, -1.64 to -0.01). For ongoing pregnancy rates after in vitro fertilization, the adjusted odds ratio for HA gel + IUD vs HA alone was 2.03 (95% CreI, 0.44-11.00) and for IUD alone vs HA alone was 1.13 (95% CreI, 0.41-3.29), indicating nonsignificant differences. There were no differences observed in endometrial thickness on the day of embryo transfer among the 3 groups.
The investigation of the primary outcome in reducing the recurrence rate IUA after treatment demonstrated that a combination of HA gel + IUD provides greater prevention of recurrent IUAs and may decrease post-treatment AFS scores for infertile women undergoing hysteroscopic adhesiolysis. However, for the secondary outcome of increasing pregnancy rates, there was no improvement in the ongoing pregnancy rates after in vitro fertilization.
比较 3 种二级预防疗法预防宫腔镜粘连松解术后宫腔粘连(IUAs)复发和提高不孕妇女妊娠率的复发率、治疗后美国生育协会(AFS)评分、持续妊娠率和子宫内膜厚度。
回顾性研究。
私立生育医院。
200 例连续就诊的不孕妇女,有生育愿望,经子宫输卵管造影检查诊断为 IUAs,于 2018 年 1 月至 2020 年 5 月接受宫腔镜粘连松解术治疗 IUAs。
接受宫腔镜粘连松解术的妇女接受激素治疗,然后进行 3 种二级预防措施之一:透明质酸(HA)凝胶单独使用、宫内节育器(IUD)单独使用或 HA 凝胶+IUD。
在最终分析的 200 名妇女中,121 名接受 HA 凝胶单独治疗,59 名接受 IUD 单独治疗,20 名接受 HA 凝胶+IUD 联合治疗。HA 凝胶+IUD 组治疗后宫腔粘连的平均治疗后 AFS 评分明显低于 HA 凝胶单独治疗组或 IUD 单独治疗组(校正后 p 值分别为 0.01 和 0.02)。多变量分析显示,HA 凝胶+IUD 治疗后的妇女复发率明显低于 HA 凝胶单独治疗组(校正优势比,0.19;95%可信区间[CrI],0.03-0.88)。HA 凝胶+IUD 治疗的妇女治疗后 AFS 评分也低于 HA 凝胶单独治疗组(β系数,-0.83;95%CrI,-1.64 至-0.01)。体外受精后持续妊娠率方面,HA 凝胶+IUD 与 HA 凝胶单独治疗的校正优势比为 2.03(95%CrI,0.44-11.00),IUD 单独治疗与 HA 凝胶单独治疗的校正优势比为 1.13(95%CrI,0.41-3.29),差异无统计学意义。三组间胚胎移植日子宫内膜厚度无差异。
对治疗后宫腔粘连复发率降低的主要结局进行研究,结果表明透明质酸凝胶+IUD 联合应用可更有效地预防宫腔粘连复发,并可能降低宫腔镜粘连松解术后不孕妇女的治疗后 AFS 评分。然而,对于增加妊娠率的次要结局,体外受精后持续妊娠率没有提高。